表 2. Antimicrobial agent resistance rate of Klebsiella pneumoniae (KP) from 2012 to 2021 .
2012–2021年肺炎克雷伯菌对抗菌药物的耐药率
| Antimicrobial agents | 2012
(n=1382, %) |
2013
(n=1664, %) |
2014
(n=1219, %) |
2015
(n=1262, %) |
2016
(n=1507, %) |
2017
(n=1579, %) |
2018
(n=1794, %) |
2019
(n=1973, %) |
2020
(n=2021, %) |
2021
(n=2487, %) |
| −: Not available for the lack of these agents in the commercial kits. | ||||||||||
| Amikacin | 3.6 | 3.7 | 2.0 | 2.8 | 2.2 | 9.3 | 13.6 | 11.6 | 14.7 | 17.3 |
| Gentamicin | 21.4 | 20.7 | 18.5 | 20.4 | 18.9 | 24.9 | 25.3 | 25.1 | 23.8 | 25.7 |
| Imipenem | 3.2 | 2.0 | 1.4 | 2.4 | 2.7 | 10.4 | 16.6 | 15.0 | 18.2 | 23.4 |
| Meropenem | − | − | − | − | − | 10.9 | 17.0 | 15.2 | 18.2 | 23.4 |
| Etapenem | − | − | − | − | − | 11.1 | 17.8 | 15.9 | 18.5 | 23.7 |
| Cefepime | 13.1 | 10.9 | 8.6 | 10.8 | 13.0 | 20.2 | 21.8 | 21.3 | 23.0 | 27.7 |
| Ceftazidime | 28.1 | 28.9 | 25.5 | 27.8 | 28.9 | 37.2 | 35.3 | 36.1 | 36.1 | 36.9 |
| Cefoperazone-sulbactam | 3.3 | 2.6 | 2.1 | 3.1 | 4.0 | 14.1 | 18.5 | 17.6 | 19.3 | 24.0 |
| Cefuroxime | − | − | − | − | − | 32.2 | 40.5 | 41.8 | 40.7 | 41.4 |
| Piperacillin | 30.4 | 31.4 | − | − | − | 45.9 | 44.5 | 45.2 | 45.1 | 46.4 |
| Piperacillin-tazobactam | 6.7 | 4.5 | 3.9 | 5.2 | 5.9 | 21.5 | 24.2 | 22.6 | 23.1 | 28.6 |
| Ampicillin-sulbactam | 34.3 | 38.0 | 33.4 | 36.0 | 32.9 | 45.2 | 43.1 | 44.8 | 43.0 | 45.3 |
| Ciprofloxacin | 25.6 | 25.9 | 24.1 | 28.0 | 29.7 | 40.5 | 41.4 | 40.0 | 38.2 | 41.8 |
| Levofloxacin | 16.1 | 17.5 | 15.9 | 19.4 | 19.4 | 29.6 | 32.0 | 31.8 | 30.5 | 36.4 |
| Trimethoprim-sulfamethoxazole | 29.7 | 30.0 | 27.2 | 31.2 | 30.0 | 35.1 | 31.8 | 31.6 | 27.3 | 32.1 |